CAM
CLDX icon

Cresset Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Cresset Asset Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-457,666
Closed -$15.3M – 1108
2021
Q2 		$15.3M Hold
457,666
– – 0.22% 43
2021
Q1 		$9.43M Hold
457,666
– – 0.15% 57
2020
Q4 		$8.02M Hold
457,666
– – 0.13% 63
2020
Q3 		$6.79M Hold
457,666
– – 0.13% 72
2020
Q2 		$5.95M Hold
457,666
– – 0.13% 73
2020
Q1 		$760K Hold
457,666
– – 0.02% 230
2019
Q4 		$1.02M Hold
457,666
– – 0.03% 204
2019
Q3 		$975K Hold
457,666
– – 0.03% 189
2019
Q2 		$1.23M Buy
+457,666
New +$1.55M 0.04% 157
2019
Q1 		– Sell
-457,667
Closed -$1.36M – 1998
2018
Q4 		$1.36M Buy
+457,667
New +$2.25M 0.08% 55

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return